Latest filing published 15 Dec 2015 for Madrigal Pharmaceuticals, INC., €101k.
Insider track record
No signal scores available.
Closed purchases
Based on 13 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -90.0%Entry US$83.65 · Close at T+365 US$8.40
- -33.7%Entry US$170.45 · Close at T+365 US$113.05
- -21.0%Entry US$223.30 · Close at T+365 US$176.40
- -29.0%Entry US$192.15 · Close at T+365 US$136.50
- +42.6%Entry US$164.50 · Close at T+365 US$234.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Keith R. Gollust: trading record in brief
This profile gathers the share dealings of Keith R. Gollust in Madrigal Pharmaceuticals, Inc. Between 17 November 2006 and 14 December 2015, the trades on record add up to 65 filings.
On the open market, the record shows 13 purchases worth €4.6M and 8 sales worth €682k. Purchases outweigh sales by €3.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 32 share grants and 11 option exercises. So far in 2015, the count stands at 1 purchase and 8 sales.
A typical purchase (the median) is worth €243k. For 13 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 46% of cases, with a median move of -3.8%. These figures describe past trades and do not predict future prices.
The latest filing, published on 15 December 2015, reports an open-market sale of €101k in Madrigal Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 4,232 days ago, on 8 April 2015. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Keith R. Gollust
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300,000 shares@ US$0.3701Common StockSEC:0001179110-15-016285:0
- 300,000 shares@ US$0.3223Common StockSEC:0001179110-15-016285:1
- 300,000 shares@ US$0.3861Common StockSEC:0001179110-15-016067:0
- 300,000 shares@ US$0.3802Common StockSEC:0001179110-15-016067:1
- 145,892 shares@ US$0.3786Common StockSEC:0001179110-15-016067:2
- 100,000 shares@ US$0.414Common StockSEC:0001179110-15-015176:0
- 188,322 shares@ US$0.5472Common StockSEC:0001179110-15-014794:0
- 22,727 shares0Common StockSEC:0001179110-15-010911:0
- 13,636 shares0Common StockSEC:0001179110-15-010911:1
- 4,545 shares0Common StockSEC:0001179110-15-010911:2
- 4,545 shares0Common StockSEC:0001179110-15-010911:3
- 4,545 shares0Common StockSEC:0001179110-15-010911:4
- 350,000 shares@ US$1.75Common StockSEC:0001179110-15-006097:0Canonical exit: 5 Jul 2015 (T+90)
- 9,756 shares0Common StockSEC:0001179110-14-011440:0
- 4,878 shares0Common StockSEC:0001179110-14-011440:1
- 2,439 shares0Common StockSEC:0001179110-14-011440:2
- 1,219 shares0Common StockSEC:0001179110-14-011440:3
- 1,219 shares0Common StockSEC:0001179110-14-011440:4
- 150,000 shares@ US$3.75Common StockSEC:0001179110-13-016608:0Canonical exit: 11 Feb 2014 (T+90)
- 8,000 shares0Common StockSEC:0001179110-13-011531:0
- 4,000 shares0Common StockSEC:0001179110-13-011531:1
- 2,000 shares0Common StockSEC:0001179110-13-011531:2
- 1,000 shares0Common StockSEC:0001179110-13-011531:3
- 1,000 shares0Common StockSEC:0001179110-13-011531:4
- 75,000 shares@ US$10.84Common StockSEC:0001179110-13-001180:0
25 of 64 declarations
